STERIS plc (STE) is currently priced at $221.13, showing a decrease of $1.06 (-0.477%) from the previous close of $222.19. With a trading volume of $95,919, representing 11% of the average, STE is displaying moderate trading activity today.
STE's latest quarterly earnings report for Tuesday, February 3rd, revealed a consensus estimate EPS of 2.53.
STE offers a forward dividend yield of 1.14%, with a dividend per share MRQ of 63 cents and a year-over-year increase of 10.0917 cents. The trailing twelve months dividend per share stands at $2.46.
The company's free cash flow is reported at $199.5 million, with notable activities including $15.7 million in stock-based compensation and $103.5 million in common stock repurchased.
STE generated $1.50 billion in revenue, resulting in a gross profit of $655.5 million. The operating income for the period was $271 million, with a net income of $192.8 million translating to an EPS of $1.96.
Key financial ratios for STE include a gross profit margin of 43.81%, an operating profit margin of 18.11%, and a net profit margin of 12.89%. The return on equity stands at 2.69, and the price-earnings ratio is reported at 32.31.
STE's balance sheet reflects total assets of $10.59 billion, with total liabilities at $3.42 billion. The company holds $423.7 million in cash and cash equivalents, contributing to a strong financial position.
This real-time financial report provides insights into STE's current performance, earnings, dividends, cash flow, and financial health.
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.